Roche’s new influenza drug Xofluza can dramatically prevent the spread of the virus when used as a preventive therapy, according to new phase 3 data. Xofluza (baloxavir marboxil) is already ...

But what kind of sickness do your symptoms point to? Here's a breakdown for COVID-19, flu and more — and why testing is so ...

Fortunately, most people with the flu feel better within about a week of their symptoms beginning. Nonetheless, the average ...

Discover the similarities between Covid, flu, and the common cold, and learn how to diagnose each one accurately with testing ...

The FDA has approved a new use for Xofluza (baloxavir marboxil) from Roche’s Genentech unit, to prevent people developing flu after coming into contact with an infectious person.

Recommended Reading Using twin viruses, startup AAVantgarde aims to extend gene therapy’s reach Roche’s antiviral drug Xofluza reduced influenza transmission among household contacts in a ...

Roche announced positive topline results of the phase III CENTERSTONE study of Xofluza (baloxavir marboxil), an antiviral, showing a reduction in the transmission of influenza viruses. The study met ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

However, they can also lower the odds you’ll develop severe complications of the flu. Doctors will usually prescribe oseltamivir (Tamiflu) or baloxavir (Xofluza) to treat the flu, although zanamivir ...

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household members – – This is the first time that any antiviral used in the ...

With changing recommendations and multiple seasonal viruses to contend with, here’s your simple guide to the 2024-2025 cold and flu season and when to call your doctor.